TY - JOUR
T1 - Membrane vesicles nanotheranostic systems
T2 - sources, engineering methods, and challenges
AU - Nie, Weidong
AU - Wu, Guanghao
AU - Zhong, Haizheng
AU - Xie, Hai Yan
N1 - Publisher Copyright:
© 2021 IOP Publishing Ltd
PY - 2021/3
Y1 - 2021/3
N2 - Extracellular vesicles (EVs) are cell secretory native components with long-circulation, good biocompatibility, and physiologic barriers cross ability. EVs derived from different donor cells inherit varying characteristics and functions from their original cells and are favorable to serve as vectors for diagnosing and treating various diseases. However, EVs nanotheranostics are still in their infancy because of their limited accumulation at lesion sites and compromised therapy efficiency. Hence, engineering modification of EVs is usually needed to further enhance their stability, biological activity, and lesion-targeting capacity. Herein, we overview the characteristics of EVs from different sources, as well as the latest developments of surface engineering and cargo loading methods. We also focus especially on advances in EVs-based disease theranostics. At the end of the review, we predict the obstacles and prospects of the future clinical application of EVs.
AB - Extracellular vesicles (EVs) are cell secretory native components with long-circulation, good biocompatibility, and physiologic barriers cross ability. EVs derived from different donor cells inherit varying characteristics and functions from their original cells and are favorable to serve as vectors for diagnosing and treating various diseases. However, EVs nanotheranostics are still in their infancy because of their limited accumulation at lesion sites and compromised therapy efficiency. Hence, engineering modification of EVs is usually needed to further enhance their stability, biological activity, and lesion-targeting capacity. Herein, we overview the characteristics of EVs from different sources, as well as the latest developments of surface engineering and cargo loading methods. We also focus especially on advances in EVs-based disease theranostics. At the end of the review, we predict the obstacles and prospects of the future clinical application of EVs.
KW - Exosomes
KW - Extracellular vesicles
KW - Nano
KW - Theranostics
UR - http://www.scopus.com/inward/record.url?scp=85102632284&partnerID=8YFLogxK
U2 - 10.1088/1748-605X/abd2c8
DO - 10.1088/1748-605X/abd2c8
M3 - Review article
C2 - 33307545
AN - SCOPUS:85102632284
SN - 1748-6041
VL - 16
JO - Biomedical Materials (Bristol)
JF - Biomedical Materials (Bristol)
IS - 2
M1 - 022009
ER -